You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 12, 2026

CRISPR Epigenome Editing in Human Cells using Plasmid DNA Transfection and mRNA Nucleofection Delivery
Published on: May 30, 2025
Tyler S Klann1,2, Gregory E Crawford2,3, Timothy E Reddy1,2,4
1Department of Biomedical Engineering, Duke University, Durham, NC, USA.
We developed CRISPR/Cas9-based epigenomic regulatory element screening (CERES) to identify gene regulatory elements controlling traits and diseases. This method enables high-throughput functional annotation of regulatory elements in their native genomic context.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: